Novel Therapeutics for Hemophilia

Authors

Sarah Lazur, Maine Medical Center

Files

Description

Presented by Sarah Lazure, MD, PGY-4, Medicine-Pediatrics Resident at the Barbara Bush Children's Hospital at Maine Medical Center

Date of Presentation: March 14th, 2024

CME available for 1 year after presentation

Please complete an evaluation in CloudCME to claim credit for this presentation.

Institution/Department

Maine Medical Center, Pediatrics

Publication Date

3-14-2024

Publisher

Maine Medical Center

City

Portland, Maine

Keywords

Hemophilia A, Hemophilia B, Pediatrics, Grand Rounds, Therapeutics for Hemophilia, Pathophysiology

Disciplines

Pediatrics

Comments

OBJECTIVES:

Review pathophysiology of hemophilia A and B To review the currently approved novel therapies for hemophilia A and B

Review the evidence behind gene therapy for treatment of hemophilia.

Sara Lazur- Resident

Recommended Citation

Lazur, Sarah, "Novel Therapeutics for Hemophilia" (2024). Pediatrics Grand Rounds. 42.
https://knowledgeconnection.mainehealth.org/pediatrics_gr/42